13F filer · CIK 1792424
Link Fund Solutions Ltd
LONDON, X0 · filing since Q4 2019 · last filing Jul 7, 2020
Reported value
$0
$-156.8M vs prior
Positions
1
New / sold out
1 / 2
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $156.8M
Top-10 weight
–
Biggest buys vs Q1 2020
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | 0 | 0 | – | – |
Biggest sells vs Q1 2020
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | Theravance Biopharma, Inc. | -4,836,864 | -100.0% | $-111.3M |
| Sold out | Evofem Biosciences, Inc. | -9,138,504 | -100.0% | $-45.5M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2020
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | 00 | 0 | $0 | – |